Mr. Illingworth has led the company since 2007 and oversaw a period of rising sales and improving margins. Olivier Bohuon, former chief executive of Pierre Fabre SA and former executive of Abbott Laboratories, will replace Mr. Illingworth.
Mr. Illingworth’s decision to retire was personal, according to the report, and unrelated to the renewed takeover speculation. Both Johnson & Johnson and Biomet have been rumored as potential buyers of the company.
Read the Wall Street Journal report on Smith & Nephew.
Read other coverage on Smith & Nephew:
– Smith & Nephew: Potential Buyers Would Pay $15.6B
– Smith & Nephew CEO Speaks About Orthopedic Device Environment
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
